Sofinnova Investments, Inc. - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 23 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sofinnova Investments, Inc. ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2020$2,065,000
-40.9%
1,012,408
-14.2%
0.15%
-30.5%
Q2 2020$3,493,000
+12.0%
1,180,1780.0%0.22%
-23.9%
Q1 2020$3,119,000
-46.8%
1,180,1780.0%0.29%
-31.7%
Q4 2019$5,865,000
-16.6%
1,180,1780.0%0.42%
-33.5%
Q3 2019$7,034,000
-7.6%
1,180,1780.0%0.64%
-9.0%
Q2 2019$7,612,000
-4.5%
1,180,1780.0%0.70%
-9.0%
Q1 2019$7,972,000
+66.0%
1,180,1780.0%0.77%
+28.4%
Q4 2018$4,803,000
-62.6%
1,180,1780.0%0.60%
-47.8%
Q3 2018$12,840,0001,180,1781.14%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q2 2020
NameSharesValueWeighting ↓
GARDNER LEWIS ASSET MANAGEMENT L P 1,249,778$2,750,0000.55%
Beryl Capital Management LLC 1,131,772$2,490,0000.26%
DELTEC ASSET MANAGEMENT LLC 155,614$342,0000.08%
Knott David M Jr 41,700$92,0000.04%
TPG GP A, LLC 1,020,748$2,246,0000.04%
GABELLI & Co INVESTMENT ADVISERS, INC. 40,900$90,0000.01%
Ergoteles LLC 135,323$298,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,600$292,0000.01%
Virtu Financial LLC 20,027$44,0000.00%
GABELLI FUNDS LLC 59,100$130,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders